Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab.

Ichiro YamauchiAkihiro YasodaShigemi MatsumotoYuichi SakamoriYoung Hak KimMotoo NomuraAtsushi OtsukaToshinari YamasakiRyoichi SaitoMorimasa KitamuraToshio KitawakiMasakatsu HishizawaNobuko Kawaguchi-SakitaToshihito FujiiDaisuke TauraMasakatsu SoneNobuya Inagaki

Published in: PloS one (2019)

By thyroid uptake of FDG-PET, overt thyroid irAEs could be predicted before nivolumab therapy. Thyroid irAEs related to good prognosis in lung cancer but might be inconclusive in malignant melanoma.

Keyphrases

pet ct
pet imaging
computed tomography
risk factors
stem cells
bone marrow
drug induced